TABLE 4

Reported Km and Vmax values for various human P450 substrates


Enzyme

Substrate

Product

Km

Vmax
1A1 7-Ethoxyresorufin Resorufin 1.4 (0.6)a,b 2.4 (0.4)
1A2 Bufuralol 1′-OH-Bufuralol 176 4.56
2B6 DZ NDZ 181 8.5
Testosterone 6β-OH-Testosterone 50.5 87
2C9 Diclofenac 4′-OH-Diclofenac 15.5 1.3
2C19 (S)-Mephenytoin 4′-OH-Mephenytoin 31-339 87-536
Bufuralol 1′-OH-Bufuralol 36 36.9
2D6 Bufuralol 1′-OH-Bufuralol 10 2.5
Metoprolol α-OH-Metaprolol 21.4 2.17
Dextromethorphan Dextrorphan 5.4, 6.5, 0.5, 1.6 0.47, 1.3, 0.5, 0.03
3A4 DZ TMZ 140 30
Testosterone 6β-OH-Testosterone 56, 93 3.5, 16.5
Dextromethorphan 3-Methoxymorphinan 660, 1155 6.7, 11.9
3A5 Testosterone 6β-OH-Testosterone 243 21
HLMs DZ NDZ 184 1.4
TMZ 188, 230 6.8, 16.2
Testosterone 6β-OH-Testosterone 67 5.3
(S)-Mephenytoin 4′-OH-Mephenytoin 11 0.07
Diclofenac 4′-OH-Diclofenac 3.7, 5.4 1.8, 1.2
Dextromethorphan Dextrorphan 11, 4.4 0.25, 5.2
3-Methoxymorphinan 850, 188-335 1.8, 1.7-2
7-Ethoxyresorufin Resorufin (low Km) 1.4 (0.2)b 1.3 (0.2)
Resorufin (high Km) 97.9 (23.8)b 10.3 (1.3)

Bufuralol
1′-OH-Bufuralol
2.8, 36, 9.4
0.1, 0.2, 0.2
  • a Km (μM) and Vmax (nmol/min/nmol) were obtained from the Metabolism and Transport Drug Interaction Database (www.druginteractioninfo.org) established by Dr. René Levy, University of Washington, Seattle, WA

  • b Data were obtained from our laboratory, and the values in parentheses are the standard deviation